Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Brabec

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
Nucleic Acids Research|September 14, 2010
Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNAJaroslav Malina, Jana Kasparkova, Nicholas P Farrell, et al.
Bioconjugate Chemistry|August 19, 2010
A metal-free DNA nuclease based on a cyclic peptide scaffoldShadad Alkhader, Aviva Ezra, Jana Kasparkova, et al.
Dalton Transactions (Cambridge, England : 2003)|May 19, 2021
Unexpected solution behaviour of ester-functionalized half-sandwich Ru(II) and Ir(III) complexesLukáš Masaryk, Ivan Nemec, Jana Kašpárková, et al.
Biochemical and Biophysical Research Communications|November 23, 2005
Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domainHana Pivonková, Marie Brázdová, Jana Kaspárková, et al.
Angewandte Chemie (International Ed. in English)|August 5, 2020
A Multi-action Pt<sup>IV</sup> Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer CellsHana Kostrhunova, Juraj Zajac, Lenka Markova, et al.
Environmental Health Perspectives|November 12, 2002
Chiral discrimination in platinum anticancer drugsMichele Benedetti, Jaroslav Malina, Jana Kasparkova, et al.
Biochemistry|May 21, 2003
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell linesJana Kasparkova, Victoria Marini, Yousef Najajreh, et al.
Journal of Inorganic Biochemistry|October 25, 2011
Platinum-DNA interstrand crosslinks: molecular determinants of bending and unwinding of the double helixTereza Suchánková, Karel Kubíček, Jana Kašpárková, et al.
Angewandte Chemie (International Ed. in English)|December 6, 2019
Platinum (IV) Derivatives with Cinnamate Axial Ligands as Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma CellsJuraj Zajac, Vojtech Novohradsky, Lenka Markova, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 12, 2019
An Anticancer Pt<sup>IV</sup> Prodrug That Acts by Mechanisms Involving DNA Damage and Different Epigenetic EffectsHana Kostrhunova, Emanuele Petruzzella, Dan Gibson, et al.
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
Nucleic Acids Research|September 14, 2010
Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNAJaroslav Malina, Jana Kasparkova, Nicholas P Farrell, et al.
Bioconjugate Chemistry|August 19, 2010
A metal-free DNA nuclease based on a cyclic peptide scaffoldShadad Alkhader, Aviva Ezra, Jana Kasparkova, et al.
Dalton Transactions (Cambridge, England : 2003)|May 19, 2021
Unexpected solution behaviour of ester-functionalized half-sandwich Ru(II) and Ir(III) complexesLukáš Masaryk, Ivan Nemec, Jana Kašpárková, et al.
Biochemical and Biophysical Research Communications|November 23, 2005
Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domainHana Pivonková, Marie Brázdová, Jana Kaspárková, et al.
Angewandte Chemie (International Ed. in English)|August 5, 2020
A Multi-action Pt<sup>IV</sup> Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer CellsHana Kostrhunova, Juraj Zajac, Lenka Markova, et al.
Environmental Health Perspectives|November 12, 2002
Chiral discrimination in platinum anticancer drugsMichele Benedetti, Jaroslav Malina, Jana Kasparkova, et al.
Biochemistry|May 21, 2003
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell linesJana Kasparkova, Victoria Marini, Yousef Najajreh, et al.
Journal of Inorganic Biochemistry|October 25, 2011
Platinum-DNA interstrand crosslinks: molecular determinants of bending and unwinding of the double helixTereza Suchánková, Karel Kubíček, Jana Kašpárková, et al.
Angewandte Chemie (International Ed. in English)|December 6, 2019
Platinum (IV) Derivatives with Cinnamate Axial Ligands as Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma CellsJuraj Zajac, Vojtech Novohradsky, Lenka Markova, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 12, 2019
An Anticancer Pt<sup>IV</sup> Prodrug That Acts by Mechanisms Involving DNA Damage and Different Epigenetic EffectsHana Kostrhunova, Emanuele Petruzzella, Dan Gibson, et al.
Pageof 25